Speakers

Explore the brilliant minds at Ai4, actively applying artificial intelligence in leading organizations and navigating our AI-powered future. See our 2026 speaker lineup below and stay tuned for our 2027 lineup.

Gevorg Grigoryan

Gevorg Grigoryan

Co-Founder and CTO

Generate Biomedicines

About Gevorg

Gevorg Grigoryan Co-Founder & Chief Technology Officer Generate:Biomedicines

Since co-founding Generate:Biomedicines, Gevorg Grigoryan, PhD, has served as Chief Technology Officer, playing a foundational role in establishing the company’s scientific vision and technological backbone. As an architect of The Generate Platform™, Gevorg has led the integration of machine learning and protein science to enable the on-demand generation of novel therapeutics across a wide range of biologic modalities. Under his scientific leadership, Generate:Biomedicines has advanced a growing pipeline of preclinical programs and clinical assets, all rooted in a generative approach to biology. Prior to founding Generate:Biomedicines, Gevorg was a tenured professor at Dartmouth College, where his interdisciplinary research across computer science, chemistry, biology, and physics contributed major insights into the principles of protein structure and function. His academic work was instrumental in demonstrating the feasibility of generative design and continues to inform the scientific direction of the company. Gevorg has authored more than 50 peer-reviewed publications in top-tier journals including Nature, Science, and PNAS. His research has earned recognition from the Alfred P. Sloan Foundation, the National Institutes of Health, the National Science Foundation, and the American Cancer Society. He holds a PhD from the Massachusetts Institute of Technology and dual bachelor’s degrees in Biochemistry and Computer Science. In his role at Generate:Biomedicines, Gevorg remains focused on driving innovation at the intersection of computation and biology and enjoys working with brilliant scientists on some of the toughest challenges in molecular and therapeutic science.

Track
Keynote
Industry
Other
Job Function
Other
Company Size
251-500 employees